The Promise and Perils of Biotech in Personalised Healthcare. Can New Regulatory Pathways Protect the Vulnerable?

Risk and Regulation Magazine 32 (Winter 2018):20-23 (2018)
Download Edit this record How to cite View on PhilPapers
Abstract
The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.
Categories
PhilPapers/Archive ID
DEGTPA-2
Upload history
Archival date: 2019-04-01
View other versions
Added to PP index
2019-04-01

Total views
38 ( #45,585 of 51,415 )

Recent downloads (6 months)
3 ( #50,625 of 51,415 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.